RCSI researchers discover new way to stop excessive inflammation



[ad_1]

PICTURE

PICTURE: Dr Claire McCoy, Senior Lecturer in Immunology at RCSI University of Medicine and Health Sciences. view After

Credit: Patrick Bolger

DUBLIN, Friday, March 5, 2021: RCSI researchers have discovered a new way to ‘curb’ excessive inflammation by regulating a type of white blood cell that is critical for our immune system.

The discovery has the potential to protect the body from the uncontrolled damage caused by inflammatory diseases.

The paper, led by researchers at RCSI University of Medicine and Health Sciences, is published in Nature communications.

When our body’s immune cells (white blood cells) called macrophages are exposed to powerful infectious agents, powerful inflammatory proteins called cytokines are produced to fight the invading infection. However, if these cytokine levels get out of control, significant tissue damage can occur.

Researchers have found that a protein called Arginase-2 works using the energy source of macrophage cells, called mitochondria, to limit inflammation. Specifically, they have shown for the first time that Arginase-2 is essential for decreasing a potent inflammatory cytokine called IL-1.

This discovery could allow researchers to develop new treatments that target the Arginase-2 protein and protect the body from the uncontrolled damage caused by inflammatory diseases.

“Excessive inflammation is an important feature of many diseases such as multiple sclerosis, arthritis, and inflammatory bowel disease. With our discovery, we may be able to develop new therapies for the treatment of diseases. inflammatory conditions and ultimately improve the quality of life of people with these conditions, ”commented lead author Dr Claire McCoy, Senior Lecturer in Immunology at RCSI.

The study was conducted by researchers at the School of Pharmacy and Biomolecular Sciences, RCSI (Dr Claire McCoy, Dr Jennifer Dowling and Ms Remsha Afzal) in collaboration with a network of international researchers from Australia, Germany and Switzerland. .

The research was funded by Science Foundation Ireland, with the early stages of the research coming from a grant from the National Health Medical Research Council, Australia.

###

About RCSI University of Medicine and Health Sciences

Ranked number one in the world for good health and well-being in the Times Higher Education (THE) Academic Impact Ranking 2020, RCSI University of Medicine and Health Sciences is an international non-profit university, headquartered in Dublin.

RCSI focuses exclusively on education and research to improve human health around the world. It is among the top 250 universities in the world in the World University Rankings (2021) and its research is ranked first in Ireland for citations. RCSI has received Athena Swan Bronze accreditation for its positive gender practices in higher education.

Visit the RCSI MyHealth Expert Directory to find details of our experts on a wide range of health issues and concerns. Recognizing their responsibility to share their knowledge and findings to give people information that leads them to better health, these clinicians and researchers are ready to engage with the media in their area of ​​expertise.

For more information please contact:

Jane Butler, Senior Communications Officer, RCSI University of Medicine and Health Sciences [email protected] | +353 87 7531877

Warning: AAAS and EurekAlert! are not responsible for the accuracy of any press releases posted on EurekAlert! by contributing institutions or for the use of any information via the EurekAlert system.

[ad_2]
Source link